alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 216.87 Wildlife research. ( a ) Wildlife research, other than research on North Pacific fur seals, including specimen collection, may be permitted on the Pribilof Islands subject to the following conditions: ( 1 ) Any person or agency, seeking to conduct such research shall first obtain any Federal or State of Alaska permit required for the type of research involved.
( 2 ) Any person seeking to conduct such research shall obtain prior approval of the Director, Pribilof Islands Program, National Marine Fisheries Service, National Oceanic and Atmospheric Administration, 1700 Westlake Avenue North, Seattle, WA 98109, by filing with the Director an application which shall include: ( i ) Copies of the required Federal and State of Alaska permits; and
( ii ) A resume of the intended research program.
( 3 ) All approved research shall be subject to all regulations and administrative procedures in effect on the Pribilof Islands, and such research shall not commence until approval from the Director is received.
( 4 ) Any approved research program shall be subject to such terms and conditions as the Director, Pribilof Islands Program deems appropriate.
( 5 ) Permission to utilize the Pribilof Islands to conduct an approved research program may be revoked by the Director, Pribilof Islands Program at any time for noncompliance with any terms and conditions, or for violations of any regulation or administrative procedure in effect on the Pribilof Islands.
[43 FR 5521, Feb. 9, 1978. Redesignated at 61 FR 11750, Mar. 22, 1996]
# EUR-Lex - 11992M/PRO/CC/04 - EN

Avis juridique important

*|*

# 11992M/PRO/CC/04

**Treaty on European Union - Protocol on the convergence criteria referred to in Article 109 J.of the Treaty establishing the European Community - Article 4 **

*
Official Journal C 191 , 29/07/1992 P. 0085 *

Article 4

The criterion on the convergence of interest rates referred to in the fourth indent of Article 109j(1) of this Treaty shall mean that, observed over a period of one year before the examination, a Member State has had an average nominal long-term interest rate that does not exceed by more than 2 percentage points that of, at most, the three best performing Member States in terms of price stability. Interest rates shall be measured on the basis of long term government bonds or comparable securities, taking into account differences in national definitions.
# EUR-Lex - 12002E184 - EN

Avis juridique important

*|*

# 12002E184

**Treaty establishing the European Community (Nice consolidated version) - Part Four: Association of the overseas countries and territories - Article 184 - Article 133 - EC Treaty (Maastricht consolidated version) - Article 133 - EEC Treaty **

*
Official Journal C 325 , 24/12/2002 P. 0112 - 0112 Official Journal C 340 , 10/11/1997 P. 0258 - Consolidated version Official Journal C 224 , 31/08/1992 P. 0054 - Consolidated version (EEC Treaty - no official publication available) *

Treaty establishing the European Community (Nice consolidated version)

Part Four: Association of the overseas countries and territories

Article 184

Article 133 - EC Treaty (Maastricht consolidated version)

Article 133 - EEC Treaty

Article 184

1. Customs duties on imports into the Member States of goods originating in the countries and territories shall be prohibited in conformity with the prohibition of customs duties between Member States in accordance with the provisions of this Treaty.

2. Customs duties on imports into each country or territory from Member States or from the other countries or territories shall be prohibited in accordance with the provisions of Article 25.

3. The countries and territories may, however, levy customs duties which meet the needs of their development and industrialisation or produce revenue for their budgets.

The duties referred to in the preceding subparagraph may not exceed the level of those imposed on imports of products from the Member State with which each country or territory has special relations.

4. Paragraph 2 shall not apply to countries and territories which, by reason of the particular international obligations by which they are bound, already apply a non-discriminatory customs tariff.

5. The introduction of or any change in customs duties imposed on goods imported into the countries and territories shall not, either in law or in fact, give rise to any direct or indirect discrimination between imports from the various Member States.
Exhibit 23.2
 
 DeGolyer and MacNaughton
 
 5001 Spring Valley Road
 Suite 800 East
 Dallas, Texas 75244








October 12, 2011




Abraxas Petroleum Corporation


18803 Meisner Drive


San Antonio, Texas 78258




Ladies and Gentlemen:






We consent to the use of the name DeGolyer and MacNaughton, to references to DeGolyer and MacNaughton, and to the inclusion of information taken from our “Appraisal Report as of December 31, 2010 on Certain Properties owned by Abraxas Petroleum Corporation,” “Appraisal Report as of December 31, 2009 on Certain Properties owned by Abraxas Petroleum Corporation,” “Appraisal Report as of December 31, 2008 on Certain Properties owned by Abraxas Energy Partners, L.P.,” “Appraisal Report as of December 31, 2008 on Certain Properties owned by Abraxas Petroleum Corporation,” and “Appraisal Report as of December 31, 2010 on Certain Properties owned by Blue Eagle Energy, LLC” (our Reports) under the sections “Item 1-Business General”, “Item 2-Properties”, “Primary Operating Areas”, and “Reserves Information” in the Abraxas Petroleum Corporation Annual Report on Form 10–K/A for the year ended December 31, 2010.  We also consent to the inclusion of our letter report dated February 22, 2011 in the Annual Report on Form 10-K/A of Abraxas Petroleum Corporation as Exhibit 99.1.  We further consent to the incorporation by reference in the Registration Statements on Form S-3 (333-127480, 333-132971, 333-162537 and 333-163763) and Form S-8 (No. 333-17375, 333-17377, 033-81416, 333-55691, 333-74592, 333-74614, 333-135032,0333-153635, 333-162358 and 333-168022) of information from our Reports.






Very truly yours,




/s/DeGolyer and MacNaughton




DeGOLYER and MacNAUGHTON


Texas Registered Engineering Firm F-716
**Final Listing of Questionnaire Files for Steam Electric Rulemaking Record**

**Plant ID 03605**  **Removed from Public**  **(Non-CBI) Docket**  **1 Copyright** 

**Flag 2**  **File Name 3**  **Description** 03605\03605_Certification Statement.PDF Plant certification statement x 03605\03605_Checklist.xls EPA Technical Review Checklist Workbook

03605\03605_Completeness Checklist.xls EPA Completeness Review Checklist x 03605\03605_Part A.xls Plant submitted survey file x 03605\03605_Part E.xls Plant submitted survey file x 03605\03605_Part H.xls Plant submitted survey file x 03605\Supporting Documents\03605_ Water Balance.pdf Plant submitted supplemental files to the survey

1Final reviewed survey responses are located in the Steam Electric Technical Questionnaire Database
. 2Copyright documents are available from the docket. 3 No hardcopy log is included for this plant as no hardcopy materials were received.
EXHIBIT 32 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I Dr. Dennis D. Keiser, President and Chief Executive Officer of Intrepid Technology & Resources, Inc., (the "Company") , do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: · the Quarterly Report on Form 10-QSB, of the Company for the quarter ended March 31, 2007, as filed with the Securities and Exchange Commission (the Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and · the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.   Date: May 14, 2007 /s/ Dr. Dennis D. Keiser  ------------------------------------------------------------------ Dennis D. Keiser Chief Executive Officer, Acting Chief Financial Officer   and,  I Bradley J. Frazee, Vice President, Secretary of Intrepid Technology & Resources, Inc., (the "Company") , do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: · the Quarterly Report on Form 10-QSB, of the Company for the quarter ended March 31, 2007, as filed with the Securities and Exchange Commission (the Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and · the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  Date: May 14, 2007 /s/ Bradley J. Frazee  ---------------------------------------------------------- Bradley J. Frazee Vice President, Secretary
#### § 260.19 When application may be withdrawn.

An application for inspection service may be withdrawn by the applicant at any time before the inspection is performed: *Provided,* That, the applicant shall pay at the hourly rate prescribed in § 260.70 for the time incurred by the inspector in connection with such application, any travel expenses, telephone, telegraph or other expenses which have been incurred by the inspection service in connection with such application.

[31 FR 16052, Dec. 15, 1966, as amended at 36 FR 18738, Sept. 21, 1971]
QuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.a.1  


 
 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    
    


        We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-92229) pertaining to the 1993
Stock Option Plan and the 1996 Employee Stock Purchase Plan and in the Registration Statement (Form S-8 No. 333-138697) pertaining to the 2006 Stock Option Plan
of Biovail Corporation, of our reports dated March 19, 2007, with respect to the consolidated financial statements and schedules of Biovail Corporation, Biovail Corporation management's
assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Biovail Corporation, included in the Annual Report
(Form 20-F) for the year ended December 31, 2006. 



	Toronto, Canada	 	/s/ ERNST & YOUNG LLP
	March 21, 2007	 	Chartered Accountants













QuickLinks


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Minority Programs Review Committee, MARC Review Subcommittee A.                    

*Date:*                         February 16, 2006.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Holiday Inn Select Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Helen R. Sunshine, PhD, Chief, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN12F, Bethesda, MD 20892, 301-594-2881,                         *sunshinh@nigms.nih.gov*.                    

                        (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical                               ( print page 4600)                            Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS)                    

Dated: January 19, 2006.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 06-778 Filed 1-26-06; 8:45 am]

BILLING CODE 4140-01-M
[Federal Register Volume 71, Number 175 (Monday, September 11, 2006)]
[Notices]
[Page 53452]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-7594]



[[Page 53452]]

=======================================================================
-----------------------------------------------------------------------

FARM CREDIT ADMINISTRATION


Farm Credit Administration Board; Sunshine Act; Regular Meeting

AGENCY: Farm Credit Administration.

SUMMARY: Notice is hereby given, pursuant to the Government in the 
Sunshine Act (5 U.S.C. 552b(e)(3)), of the regular meeting of the Farm 
Credit Administration Board (Board).
    Date and Time: The regular meeting of the Board will be held at the 
offices of the Farm Credit Administration in McLean, Virginia, on 
September 14, 2006, from 9 a.m. until such time as the Board concludes 
its business.

FOR FURTHER INFORMATION CONTACT: Roland E. Smith, Secretary to the Farm 
Credit Administration Board, (703) 883-4009, TTY (703) 883-4056.

ADDRESSES: Farm Credit Administration, 1501 Farm Credit Drive, McLean, 
Virginia 22102-5090.

SUPPLEMENTARY INFORMATION: Parts of this meeting of the Board will be 
open to the public (limited space available), and parts will be closed 
to the public. In order to increase the accessibility to Board 
meetings, persons requiring assistance should make arrangements in 
advance. The matters to be considered at the meeting are:

Open Session

    A. Approval of Minutes
    <bullet> August 10, 2006 (Open)
    B. New Business
    1. Regulations
    <bullet> Financing for Processing and Marketing--Proposed Rule
    <bullet> Privacy Act and Security Information--Final Rule
    1. Reports
    <bullet> Farm Credit System Building Association Quarterly Report

Closed Session*

    <bullet> Office of Secondary Market Oversight Quarterly Report
    *Session Closed--Exempt pursuant to 5 U.S.C. 552b(c)(8) and (9).

    Dated: September 6, 2006.
Roland E. Smith,
Secretary, Farm Credit Administration Board.
[FR Doc. 06-7594 Filed 9-07-06; 12:27 pm]
BILLING CODE 6705-01-P
Document

AMENDMENT #1 TO CO-PROMOTION AGREEMENT 


This Amendment #1 ("Amendment") is signed as of the signature date(s) below and made effective as of January 1, 2019 ("Effective Date") by and between Janssen Biotech, Inc. ("JBI") and Exagen Diagnostics Inc. ("Exagen") and amends that Co-Promotion Agreement effective as of December 10, 2018 by and between JBI and Exagen, with contract reference number C2018017807 and iCD reference number 1251568 ("Agreement"). All terms not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement.
WHEREAS, JBI and Exagen find it in their respective interests to amend the Agreement. 


NOW, THEREFORE, in consideration of the premises and of the mutual promises and covenants herein contained, the parties hereto agree as follows: 


1.TrxU Baseline of Exhibit A in the Agreement, on page 16, is hereby amended by deleting it in its entirety and replacing it with the following:


(A)(1)  TRxU Baseline 2019 and 2020
						
	[***]	


						
	[***]	


        
2.(A)(2) Sample Promotion Fee Calculation of Exhibit A in the Agreement, on page 17, is hereby amended by deleting it in its entirety and replacing it with the following:
						
	[***]	


3.Except as specifically amended hereby, all terms of the Agreement remain in full force and effect. In the event of any conflict between the Agreement and this Amendment, the provisions of this Amendment shall prevail.


IN WITNESS WHEREOF, the parties have caused this Amendment to be executed by their duly authorized representatives.


									
	Janssen Biotech, Inc.		Exagen Diagnostics Inc.
	By: /s/ Leslie Schorr		By: /s/ Ron Rocca
	Name: Leslie Schorr		Name: Ron Rocca
	Title: Therapeutic Area Lead, NBD		Title: CEO
	Date: Aug 22, 2019		Date: Aug 20, 2019
























									
			
	***	Certain Confidential Information Omitted
#### Barnet Lippman, Respondent, *v.*Leopold Gottesman, Appellant.

(Supreme Court, Appellate Term,

February, 1910.)

Guaranty — Discharge of guarantor — Extension of time for payment or other performance — Extension as to part.

Where goods are sold from time to time under a continuing guaranty for the payment of the price, an extension of the term of credit as to some of the goods by talcing notes therefor does not discharge the guarantor from liability for the remainder as to which there was no extension.

Appeal by the defendant from a judgment of the Municipal Court of the city of New York, sixth district, borough of Manhattan, rendered in favor of the plaintiff after a trial by the court without a jury.

Harold H. Cohen, for appellant.

Phillips & Samuels, for respondent.

*Per Curiam.*

The facts are not in dispute. Defendant had given a continuing guaranty of the price of goods to be sold to his brother-in-law, one Mandell, by the plaintiff, on credit of sixty days. From March 7, 1907, to December 3, 1908, plaintiff sold various goods to Mandell, who neglected to pay at the end of the term of credit. In some instances notes were taken from him which operated as an extension of the credit and discharged the guarantor as to the amounts covered thereby. The indebtedness now sued for is for goods sold on sixty days’ credit after December 3, 1908, and as to which there has been no extension of time. Defendant contends that the 'guaranty was terminated altogether by the prior extensions. We consider ourselves bound by Klein v. Long, 27 App. Div. 158, to hold to the contrary, and affirm the judgment.

Present: Seabury, Guy and Whitney) JJ.

Judgment affirmed with costs.
a. Assumed Pit/Mound (above)

. The assumed pit/mound represents the typical configuration and maximum likely dimensions of an overturning alteration to the cross section. It is provided as a standard basis for scour analysis. b. Potential Pit (above)

. The potential pit is the total cross sectional area subject to loss on overturning. Because the direction of overturning may not be known in advance of overturning, the potential pit must account for overturning in any possible direction. It is provided as a means to determine whether or not overturning alone, without consideration for scour, would impact the prism.

Maximum Plant Height (in feet, at maturity or as maintained) < 10 10

- 20 20

- 30 30

- 40 40

- 60 60

- 80 80

- 100 >100

Depth (D)

NA 2 3 4 5 6 7 c ase by

case Length/Height (2D) 4 6 8 10 12 14

Width (3D) 6 9 12 15 18 21

c. Pit/Mound Dimension Values (above , in feet )

. Pit/mound dimensions other than the above may be considered for situations in which (a) the variance request presents reliable supporting information or (b) the ATR team deems it appropriate based on specific conditions.

Enclosure 3, Figure 2: Pit/Moun d Topography

. The cross sections above assume no slope and must be adapted to actual slope conditions.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<RESTATED>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               MAR-31-2000             MAR-31-1999
<CASH>                                         122,857                 247,929
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  326,058                 171,626
<ALLOWANCES>                                    27,751                   2,994
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                               540,989                 553,663
<PP&E>                                       5,642,367               2,058,236
<DEPRECIATION>                               1,209,114               1,068,378
<TOTAL-ASSETS>                               6,179,452               1,595,123
<CURRENT-LIABILITIES>                          450,609                 337,187
<BONDS>                                      1,251,742                  82,237
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                         2,106                       0
<OTHER-SE>                                   3,941,469                 505,126
<TOTAL-LIABILITY-AND-EQUITY>                 6,179,452               1,595,123
<SALES>                                              0                       0
<TOTAL-REVENUES>                               300,849                 189,158
<CGS>                                                0                       0
<TOTAL-COSTS>                                  263,450                 181,391
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                   3,094
<INCOME-PRETAX>                                 42,178                   7,564
<INCOME-TAX>                                     9,701                 (3,772)
<INCOME-CONTINUING>                             32,477                  11,336
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                    32,477                  11,336
<EPS-BASIC>                                       0.15                    0.10<F2>
<EPS-DILUTED>                                     0.15                    0.10<F2>
<FN>
<F1>1999 has been restated due to the Reverse Acquisition of Transocean Offshore
Inc. by Sedco Forex.
<F2>Basic and Diluted Earnings per share are shown on a Pro Forma basis.
</FN>


</TABLE>